February 1, 2023 February 1, 2023Categories AnnouncementsOngoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer
January 30, 2023 January 30, 2023Categories News StoriesNow Enrolling: The BRIDGE research study is evaluating a new treatment approach for patients with early bladder cancer
January 24, 2023 January 24, 2023Categories News StoriesBlinatumomab significantly improves overall survival in newly diagnosed B-ALL patients who are MRD-negative after initial treatment (study E1910)
December 20, 2022 December 20, 2022Categories Announcements News StoriesThe November/December 2022 News from ECOG-ACRIN blog is now available
December 19, 2022 December 19, 2022Categories News StoriesBlinatumomab Plus Consolidation Chemotherapy Significantly Reduces Risk of Death in MRD-Negative B-Cell ALL
December 15, 2022 December 15, 2022Categories News StoriesStudy E1910 consolidates the role of blinatumomab in acute lymphoblastic leukemia (ALL)
December 14, 2022 December 14, 2022Categories News StoriesBlinatumomab further improves survival among patients with B-ALL and a good prognosis (study E1910)
December 13, 2022 December 13, 2022Categories News StoriesImmunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL
December 13, 2022 December 13, 2022Categories News StoriesHealthDay News informs the public of the 12-year TAILORx results
